No UK Summary of Product Characteristics (SmPC) or European Public Assessment Report (EPAR) currently exists for this medicine
In these scenarios, patients may additionally experience a reduction in efficacy and less predictable blood glucose levels until their previous dose steady-state is achieved [23]
Although individual primary studies indicated that baseline characteristics do not significantly affect the results, combining outcomes from multiple primary studies in meta-analyses could be influenced by these differences
The half-life of retatrutide is approximately 6 days, which allows for once-weekly administration
Benzyl alcohol is a preservative that acts as a bacteriostatic agent
When GLP-1 works well, its easier to: Eat normal-sized portions Avoid constant snacking Keep blood sugar more stable When GLP-1 is not as effective, it can be harder to: Stop eating once you start Say no to cravings Stay in a calorie deficit long enough to lose weight Modern weight-loss treatments based on GLP-1 are built on this idea: instead of fighting hunger with willpower, they target the hormone that drives those hunger signals in the first place
